Expert Opinion on Pharmacotherapy

Article	Citations
Pneumocystis jirovecii: a review with a focus on prevention and treatment	52
Can NSAIDs and Acetaminophen Effectively Replace Opioid Treatment Options for Acute Pain?	31
Escalating antimicrobial resistance among Enterobacteriaceae: focus on carbapenemases	31
An update on current and advancing pharmacotherapy options for the treatment of H. pylori infection	30
An update on direct antiviral agents for the treatment of hepatitis C	28
Are 5-HT1 receptor agonists effective anti-migraine drugs?	28
New anti-seizure medication for elderly epilepsy patients - a critical narrative review	27
New approved and emerging pharmacological approaches to alcohol use disorder: a review of clinical studies	24
Pediatric prolonged-release melatonin for insomnia in children and adolescents with autism spectrum disorders	23
Vericiguat for the treatment of heart failure: mechanism of action and pharmacological properties compared with other emerging therapeutic options	23
Current pharmacotherapy of cryptosporidiosis: an update of the state-of-the-art	22
AVP-786 as a promising treatment option for Alzheimer’s Disease including agitation	22
Pharmacological management of post-stroke depression: an update of the evidence and clinical guidance	22
GLP-1/GIP analogs: potential impact in the landscape of obesity pharmacotherapy	21
An evaluation of difelikefalin as a treatment option for moderate-to-severe pruritus in end stage renal disease	21
Dotinurad: a novel selective urate reabsorption inhibitor for the treatment of hyperuricemia and gout	21
The role of sulfonylureas in the treatment of type 2 diabetes	20
How urgent is the need for new antifungals?	20
An evaluation of avatrombopag for the treatment of thrombocytopenia	20
Advances with androgen deprivation therapy for prostate cancer	19
Are thiazolidinediones a preferred drug treatment for type 2 diabetes?	19
Current pharmacotherapy for methicillin-resistant Staphylococcus aureus (MRSA) pneumonia	18
An update on the use of sphingosine 1-phosphate receptor modulators for the treatment of relapsing multiple sclerosis	18
An overview of anamorelin as a treatment option for cancer-associated anorexia and cachexia	18
Mycoplasma pneumoniae: a pathogen with unsolved therapeutic problems	18

The role of amikacin in the treatment of nontuberculous mycobacterial disease	18
Emerging and state of the art hemagglutinin-targeted influenza virus inhibitors.	18
An overview of pharmacotherapy for cerebral vasospasm and delayed cerebral ischemia after subarachnoid hemorrhage	17
Careful use to minimize adverse events of oral antidiabetic medications in the elderly	17
A review of a new voltage-gated Ca2+ channel α2δ ligand, mirogabalin, for the treatment of peripheral neuropathic pain	17
Advances in pharmacotherapies for hyperuricemia	16
The state-of-the-art pharmacotherapeutic options for the treatment of chronic non-cancer pain	16
State-of-the-art, approved therapeutics for the pharmacological management of osteosarcoma	15
Current and emerging pharmacotherapy for Gaucher disease in pediatric populations	15
Novel synthetic treatment options for migraine	15
The evolving atopic dermatitis management landscape	15
Long-term management of multiple sclerosis patients treated with cladribine tablets beyond year 4	15
The complement system: a novel therapeutic target for age-related macular degeneration	15
Managing dyslipidemia in patients with Type 2 diabetes	14
Evaluating rimegepant for the treatment of migraine	14
Bexagliflozin for type 2 diabetes: an overview of the data	14
What is the impact of catechol-O-methyltransferase (COMT) on Parkinson’s disease treatment?	14
Current and emerging pharmacotherapy for recurrent bacterial vaginosis	14
Improving adherence to pharmacological treatment for schizophrenia: a systematic assessment	14
Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients	14
State-of-the-art pharmacological approaches to reduce chorea in Huntington’s disease	14
Pharmacological management of secondary spinal cord injury	14
Pharmacological strategies to treat attacks of episodic migraine in adults	14
Pharmacological strategies for smoking cessation in patients with chronic obstructive pulmonary disease: a pragmatic review	13
Real-World Evidence for Long-Term Safety and Effectiveness of Ipragliflozin in Japanese Patients with Type 2 Diabetes Mellitus: final Results of a 3-Year Post-Marketing Surveillance Study (STELLA-LONG	13
Dapagliflozin for the treatment of type 2 diabetes mellitus – an update	13
Ensitrelvir as a potential treatment for COVID-19	13
Advances in pharmacotherapy for diabetic foot osteomyelitis	13
Current and promising pharmacotherapeutic options for candidiasis	13
Advances with lipid-lowering drugs for pediatric patients with familial hypercholesterolemia	13
Are drug treatment strategies really effective against alopecia areata?	13
Current and emerging drug treatment strategies for polycystic ovary syndrome	12
Pharmacological management of cannabinoid hyperemesis syndrome: an update of the clinical literature	12
Perspectives on the current pharmacotherapeutic strategies for management of functional neuroendocrine tumor syndromes	12
Development of the PARP inhibitor talazoparib for the treatment of advancedBRCA1andBRCA2mutated breast cancer	12
Long-acting antipsychotics in the treatment of schizophrenia: opportunities and challenges	11
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art?	11
Topical hedgehog inhibitors for basal cell carcinoma: how far away are we?	11
Advances in the pharmacological management of bacterial peritonitis	11
Pharmacotherapy for hypertensive urgency and emergency in COVID-19 patients	11
Androgens and acne: perspectives on clascoterone, the first topical androgen receptor antagonist	11
Recent advances in treating hypertriglyceridemia in patients at high risk of cardiovascular disease with apolipoprotein C-III inhibitors	11
Efficacy and safety of triple combination therapy for treating chronic obstructive pulmonary disease: an expert review	11
Current and emerging pharmacotherapy for chronic spontaneous Urticaria: a focus on non-biological therapeutics	11
Current pharmacotherapeutic strategies for Strongyloidiasis and the complications in its treatment	11
Pharmacological treatment of focal epilepsy in adults: an evidence based approach	11
The management of hematologic malignancies during the COVID-19 pandemic	10
What are the main considerations when prescribing pharmacotherapy for Parkinson’s disease?	10
Paxlovid as a potential treatment for long COVID	10
Advances in the pharmacotherapeutic management of esophageal squamous cell carcinoma	10

Tazemetostat: a treatment option for relapsed/refractory follicular lymphoma	10
An overview of current and emerging antifungal pharmacotherapy for invasive fungal infections	10
Advances in cyclin-dependent kinase inhibitors for the treatment of melanoma	10
Advances in the psychopharmacotherapy of bipolar disorder type I	10
An evaluation of roxadustat for the treatment of anemia associated with chronic kidney disease	10
Is pharmacotherapy useful for treating personality disorders?	10
Pharmacological considerations for the treatment of COVID-19 in people living with HIV (PLWH)	10
An evaluation of aumolertinib for the treatment of EGFR T790M mutation-positive non-small cell lung cancer	9
An update on the available and emerging pharmacotherapy for adults with testosterone deficiency available in the USA	9
Alpelisib for the treatment of PIK3CA-mutated, hormone receptor-positive, HER2-negative metastatic breast cancer	9
Current and future pharmacotherapy options for drug-resistant epilepsy	9
Pharmacotherapy for recurrent respiratory papillomatosis (RRP): a treatment update	9
Pharmacotherapeutic management of trigeminal neuropathic pain: an update	9
Can pharmacotherapy improve treatment outcomes in people with co-occurring major depressive and cocaine use disorders?	9
An update on antidepressant pharmacotherapy in late-life depression	9
State-of-the-art beta-adrenoreceptor agonists for the treatment of asthma	9
Evaluating orelabrutinib as a novel treatment option for relapsed/refractory chronic lymphocytic leukemia in China	9
Combinational therapies for the treatment of advanced cervical cancer	9
Pharmacotherapy for artemisinin-resistant malaria	9
Patterns of comorbidity and psychopharmacology in adults with intellectual disability and attention deficit hyperactivity disorder: an UK national cross-sectional audit	9
Expert guidance on the management and challenges of long-COVID syndrome: a systematic review	9
Drug treatment options for acute promyelocytic leukemia	9
An update on the impact of depression on the treatment of psoriasis	9
The clinical evidence of second-generation H1-antihistamines in the treatment of allergic rhinitis and urticaria in children over 2 years with a special focus on rupatadine	9
Evaluating everolimus for the treatment of breast cancer	9
Evaluating pimavanserin as a treatment for psychiatric disorders: A pharmacological property in search of an indication	9
Pharmacological strategies for improving the prognosis of glioblastoma	8
The pharmacological treatment and management of hyperhidrosis	8
Does hydroxychloroquine still have any role in the COVID-19 pandemic?	8
Update on novel antipsychotics and pharmacological strategies for treatment-resistant schizophrenia	8
Current and emerging gonadotropin-releasing hormone (GnRH) antagonists for the treatment of prostate cancer	8
Considerations for single- versus multiple-drug pharmacotherapy in the management of painful diabetic neuropathy	8
An update of targeted therapeutic options for primary Sjögren syndrome: current status and future development	8
Alitretinoin for the treatment of severe chronic eczema of the hands	8
Osilodrostat for the treatment of Cushing’s disease	8
Desvenlafaxine in the treatment of major depression: an updated overview	8
Advances in the pharmacological management of non-24-h sleep-wake disorder	8
Protein kinase inhibitors for the treatment of prostate cancer	8
The effect of dapagliflozin on ventricular arrhythmias, cardiac arrest, or sudden death in people with heart failure: a tick in another box for sodium-glucose cotransporter 2 inhibitors	8
Current and emerging gluconeogenesis inhibitors for the treatment of Type 2 diabetes	8
Does antipsychotic combination therapy reduce the risk of hospitalization in schizophrenia?	7
Vortioxetine in management of major depressive disorder – a favorable alternative for elderly patients?	7
Pharmacotherapeutic advances for chronic idiopathic constipation in adults	7
Advances in pharmacotherapy for acute kidney injury	7
Current advancements in pharmacotherapy for cancer cachexia	7
Advances in the pharmacotherapeutic options for primary nodal peripheral T-cell lymphoma	7
A 2023 update on the advancements in the treatment of agitation in Alzheimer’s disease	7
Recent advances in the opioid mu receptor based pharmacotherapy for rheumatoid arthritis	7
An update on pharmacotherapeutic strategies for obesity	7
Current and promising therapeutic options for Dravet syndrome	7
Pharmacotherapeutic considerations for late-onset epilepsy	7
Advances in pharmacotherapy for neuroblastoma	7
Efficacy and safety of thrombopoietin receptor agonists in children and adults with persistent and chronic immune thrombocytopenia: a meta-analysis	7
Venetoclax as a therapeutic option for the treatment of chronic lymphocytic leukemia: the evidence so far	7
Effectiveness, persistence of use, and safety of orlistat and liraglutide in a group of patients with obesity	7
An evaluation of ibrexafungerp for the treatment of invasive candidiasis: the evidence to date	7
The evidence to date on umbralisib for the treatment of refractory marginal zone lymphoma and follicular lymphoma	7
A review of the pharmacotherapeutic considerations for managing epilepsy in people with autism	7
Recent advances in the pharmacotherapeutic management of diabetic kidney disease	7
New and emerging pharmacological treatment options for acromegaly	7
Current and emerging drug treatment strategies to tackle invasive community-associated methicillin-resistant Staphylococcus aureus (MRSA) infection: what are the challenges?	7
Evaluating posaconazole, its pharmacology, efficacy and safety for the prophylaxis and treatment of fungal infections	7
Pharmacotherapy for the treatment of recurrent cervical cancer: an update of the literature	7
Advances in pharmacotherapy for ulcerative colitis: a focus on JAK1 inhibitors	7
Immunosuppression in uterus transplantation: from transplant to delivery	7
Advances in pharmacotherapy for acute and recurrent pericarditis	7
Evaluating filgotinib for the treatment of rheumatoid arthritis	6
The revolution of personalized pharmacotherapies for cystic fibrosis: what does the future hold?	6
Metformin as a potential treatment for COVID-19	6
Moving from serotonin to serotonin-norepinephrine enhancement with increasing venlafaxine dose: clinical implications and strategies for a successful outcome in major depressive disorder	6
State-of-the-art glucocorticoid-targeted drug therapies for the treatment of rheumatoid arthritis	6
The pharmacotherapeutic management of comorbid bipolar disorder and alcohol use disorder	6
Nonsteroidal anti-inflammatory drugs in end-stage kidney disease: dangerous or underutilized?	6
Evaluating larotrectinib for the treatment of advanced solid tumors harboring an NTRK gene fusion	6
Pharmaceutical management of sexual dysfunction in men on antidepressant therapy	6
Advances in biologic and small molecule therapies for hidradenitis suppurativa	6
The state-of-the-art pharmacotherapeutic management of neovascular age-related macular degeneration	6
Treatment of severe COVID-19: an evolving paradigm	6
Key considerations in the pharmacological management of treatment-resistant depression	6
How treatable is narcolepsy with current pharmacotherapy and what does the future hold?	6

What’s new on the front-line of gout pharmacotherapy?	6
Current factor IX replacement options for hemophilia B and the challenges ahead	6
Current and emerging immunomodulators for treatment of SARS-CoV2 infection (COVID-19)	6
Efficacy and safety of Tregopil, a novel, ultra-rapid acting oral prandial insulin analog, as part of a basal-bolus regimen in type 2 diabetes: a randomized, active-controlled phase 2/3 study	6
Azole resistance in Aspergillus species: promising therapeutic options	6
Advances in pharmacotherapy for head and neck cancer	6
Evaluating upadacitinib for the treatment of psoriatic arthritis	6
An update on potential pharmacotherapies for cognitive impairment in bipolar disorder	6
Pharmacologic agents directed at the treatment of pain associated with maladaptive neuronal plasticity	6
Current challenges in the pharmacological management of genitourinary syndrome of menopause	6
An up-to-date evaluation of dolutegravir/abacavir/lamivudine for the treatment of HIV	6
A systematic review of the effect of semaglutide on lean mass: insights from clinical trials	6
Pharmacological strategies for sexual recovery in men undergoing antipsychotic treatment	6
An evaluation of cabotegravir for HIV treatment and prevention	6
An update on current pharmacotherapy for vulvar cancer	6
Vibegron for the treatment of overactive bladder: a comprehensive update	6
How do we address treating the negative symptoms of schizophrenia pharmacologically?	6
Pharmacological treatment options for heart failure with reduced ejection fraction: A 2022 update	6
Pharmacotherapy for female sexual dysfunctions (FSDs): what is on the market and where is this field heading?	6
Advances in pharmacotherapy for advanced thyroid cancer of follicular origin (PTC, FTC). New approved drugs and future therapies	6
Rethinking the use of hypnotics for treatment of insomnia in the elderly	5
Using adjuvant pharmacotherapy in the treatment of type 1 diabetes	5
Pharmacotherapy for children with elevated levels of lipoprotein(a): future directions	5
An evaluation of palbociclib as a breast cancer treatment option: a current update	5
Cytopenic myelofibrosis: prevalence, relevance, and treatment	5
The landscape of systemic therapy for early stage triple-negative breast cancer	5
Current pharmacotherapy and future directions for neuroendocrine causes of female infertility	5
Tafenoquine for the treatment of Plasmodium vivax malaria	5
Management of schizophrenia in women during the perinatal period: a synthesis of international recommendations	5
An update on the efficacy and safety of novel anticoagulants for cancer associated thrombosis	5
Pharmacotherapeutic combinations for the treatment of Alzheimer’s disease	5
Approved and emerging Bruton’s tyrosine kinase inhibitors for the treatment of chronic lymphocytic leukemia	5
Current trends in the use of anticoagulant pharmacotherapy in the United Kingdom are changes on the horizon?	5
An evaluation of canagliflozin for the treatment of type 2 diabetes: an update	5
Pharmacotherapeutic considerations for the treatment of posttraumatic stress disorder during and after pregnancy	5
An evaluation of buparlisib for the treatment of head and neck squamous cell carcinoma	5
Colesevelam – a bile acid sequestrant for treating hypercholesterolemia and improving hyperglycemia	5
Guidance for the pharmacological management of COVID-19 in the emergency setting	5
What considerations are there for the pharmacotherapeutic management of nonalcoholic steatohepatitis?	5
An overview of adapalene and benzoyl peroxide once-daily topical gel as a therapeutic option for acne	5
Advances in the pharmacotherapeutic management of refractory peptic ulcers	5
Perspectives on the use of non-biological pharmacotherapy for adult-onset Still’s disease	5
Nonselective proteasome inhibitors in multiple myeloma and future perspectives	5
Exploring the nexus of binge eating disorder (BED), New Psychoactive Substances (NPS), and misuse of pharmaceuticals: charting a path forward	5
GnRH agonists and antagonists in therapy of symptomatic uterine fibroids – current roles and future perspectives	5
The pharmacotherapeutic management of patients with myelofibrosis: looking beyond JAK inhibitors	5
An evaluation of long-acting cabotegravir + rilpivirine for the treatment of virologically suppressed adults living with HIV	5
Perioperative pharmacotherapy to prevent cardiac complications in patients undergoing noncardiac surgery	5
Recent updates in the use of pharmacological therapies for downstaging in patients with hepatocellular carcinoma	5
An up-to-date evaluation of abiraterone for the treatment of prostate cancer	5
Individualizing the treatment of patients with heart failure with reduced ejection fraction: a journey from hospitalization to long-term outpatient care	5
Considerations for prescribing pharmacotherapy for the treatment of erectile dysfunction	5
How do we optimize the prescribing of intravenous polymyxins to increase their longevity and efficacy in critically ill patients?	5
Current therapeutic options for glioblastoma and future perspectives	5
An evaluation of meropenem/vaborbactam for the treatment of nosocomial pneumonia	5
Real-world efficacy of adjuvant single-agent intravesical gemcitabine for non-muscle invasive bladder cancer	5
An update on brivaracetam for the treatment of pediatric partial epilepsy	5
Advances in pharmacotherapeutics for hepatocellular carcinoma	5
Evaluating fostemsavir as a therapeutic option for patients with HIV	5
Late phase completed clinical trials investigating bromocriptine mesylate quick release as treatment of type 2 diabetes mellitus	5
Evaluating gliclazide for the treatment of type 2 diabetes mellitus	5
Besifovir dipivoxil maleate: a novel antiviral agent with low toxicity and high genetic barriers for chronic hepatitis B	5
Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals	5
The treatment of advanced lung adenocarcinoma with activating EGFR mutations	5
A narrative review of anti-obesity medications for obese patients with osteoarthritis	5
Pharmacological strategies to reduce anthracycline-associated cardiotoxicity in cancer patients	5
Advances in the available pharmacotherapy for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation	5
An evaluation of relugolix/estradiol/norethindrone acetate for the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women	5
Advances in pharmacotherapy for rosacea: what is the current state of the art?	5
Advances in non-biological drugs for the treatment of rheumatoid arthritis	5
Treatment of type 2 diabetes in children: what are the specific considerations?	5